Overview
Aya Sugiyama practices in Hiroshima, Japan. Ms. Sugiyama is rated as an Advanced expert by MediFind in the treatment of COVID-19. Her top areas of expertise are Hepatitis B, Hepatitis, Hepatitis C, and COVID-19.
Her clinical research consists of co-authoring 67 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 11 articles in the study of COVID-19.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- COVID-19Ms. Sugiyama isAdvanced. Learn about COVID-19.
- HepatitisMs. Sugiyama isAdvanced. Learn about Hepatitis.
- Hepatitis BMs. Sugiyama isAdvanced. Learn about Hepatitis B.
- Hepatitis CMs. Sugiyama isAdvanced. Learn about Hepatitis C.
- Severe Acute Respiratory Syndrome (SARS)
- Experienced
- CirrhosisMs. Sugiyama isExperienced. Learn about Cirrhosis.
- Hepatitis AMs. Sugiyama isExperienced. Learn about Hepatitis A.
- Hepatitis DMs. Sugiyama isExperienced. Learn about Hepatitis D.
- Hepatitis EMs. Sugiyama isExperienced. Learn about Hepatitis E.
- Liver CancerMs. Sugiyama isExperienced. Learn about Liver Cancer.
- Long Haul COVIDMs. Sugiyama isExperienced. Learn about Long Haul COVID.